• Research Centers

    Key research initiatives at the Moran Eye Center include the Intermountain Ocular Research Center, Sharon Eccles Steele Center for Translational Medicine (SCTM), and Utah Retinal Reading Center (UREAD).

  • Angelucci Laboratory

    Alessandra Angelucci's research focuses on identifying neuronal circuits that underlie functional properties of neurons in the visual cerebral cortex and, ultimately, visual perception.

    Alessandra Angelucci, MD, PhD

  • Baehr Laboratory

    Dr. Baehr’s laboratory continues the hunt for genes implicated in blinding retinal degenerations using techniques from molecular biology, biochemistry, and neurobiology.

    Wolfgang Baehr, PhD

  • Bernstein Laboratory

    The Bernstein Laboratory explores the biochemistry and biophysics of nutritional interventions against inherited and acquired ocular disorders.

    Paul S. Bernstein, MD, PhD

  • The Hageman Laboratory

    Dr. Hageman's primary research interest over the past 20 years has been directed toward assessment of pathways involved in the etiology of age-related macular degeneration (AMD), the leading cause of irreversible worldwide blindness.

    Gregory S. Hageman, PhD

  • The Hartnett Lab

    Mary Elizabeth Hartnett, MD, is the principal investigator of a National Institutes of Health-funded laboratory that studies mechanisms of normal and aberrant angiogenesis, particularly related to diabetic retinopathy, retinopathy of prematurity, and age-related macular degeneration.

    Mary Elizabeth Hartnett, MD

  • The Hwang Lab

    The Hwang Lab studies how the biochemistry and extracellular matrix structure of the vitreous changes throughout life from childhood through old age.

    Eileen Hwang, MD, PhD

  • The Jones Laboratory

    The Jones Laboratory studies retinal circuitry/connectomics and metabolomics in neural plasticity in retinal disease.

    Bryan W. Jones, PhD

  • The David Krizaj Laboratory

    The Krizaj lab is interested in "what makes cells alive". The main research model, the retinal photoreceptor, is a complex and highly specialized sensory neuron whose function is to transform light into electrical impulses.

    David Krizaj, PhD

  • Overview

    We are now studying the causes, prevention, and treatment of posterior capsule opacification and development of IOLs from new soft biomaterials.

    Nick Mamalis, MD & Liliana Werner, MD, PhD

  • The Noudoost Laboratory

    The ultimate goal of the Noudoost lab research is an understanding of the neural basis of selective attention and working memory.

    Behrad Noudoost, PhD

  • The Ning Tian Laboratory

    Neuronal signals are processed in vertebrate CNS through parallel synaptic pathways. These synaptic pathways are formed with distinct cellular and molecular components and, in some cases, regulated by different mechanisms during development.

    Ning Tian, MD, PhD

  • Vinberg Laboratory

    The Vinberg Laboratory works to understand mechanisms in the retina that enable vision over a wide range of light intensities and colors, and how these mechanisms are affected in major blinding diseases including age-related macular degeneration and diabetic retinopathy.

    Frans Vinberg, PhD

  • Jun Yang Laboratory

    The research in Dr. Yang’s laboratory is focused on the disease mechanisms and therapeutic treatments for retinal degenerative diseases using mouse models.

    Jun Yang, PhD

  • The Owen Lab

    The Owen lab is an NEI-funded center working to understand the genetic and molecular causes for blinding eye disease, including retinopathy of prematurity, pediatric strabismus and amblyopia, and age-related macular degeneration.

    Leah Owen, MD, PhD

  • Utah Retinal Reading Center (UREAD)

    The Utah Retinal Reading Center (UREAD) seeks to contribute to the characterization of manifestation and progression of ophthalmic diseases, focusing on the evaluation of treatment response to innovative therapeutic strategies. Using multimodal imaging technology, UREAD specializes in the standardized and systematic analysis (“grading”) of retinal imaging data within multicenter observational studies and interventional trials.

    Steffen Schmitz-Valckenberg, MD